drugset / Trial / NCT02803307
Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is a multi-site, randomized, open-label, parallel, and single-dose administration study to investigate the safety and efficacy of TLC599 in subjects with osteoarthritis of the knee.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TLC599 | Other / unclassified | 6 mg | Other |
| Subject | TLC599 | Other / unclassified | 12 mg | Other |